List of Tables
Table 1. Dipeptidyl Peptidase-4 Inhibitors Market Trends
Table 2. Dipeptidyl Peptidase-4 Inhibitors Market Drivers & Opportunity
Table 3. Dipeptidyl Peptidase-4 Inhibitors Market Challenges
Table 4. Dipeptidyl Peptidase-4 Inhibitors Market Restraints
Table 5. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Company (2019-2024)
Table 7. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Dipeptidyl Peptidase-4 Inhibitors Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Dipeptidyl Peptidase-4 Inhibitors Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Dipeptidyl Peptidase-4 Inhibitors
Table 13. Global Dipeptidyl Peptidase-4 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase-4 Inhibitors as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Dipeptidyl Peptidase-4 Inhibitors Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Dipeptidyl Peptidase-4 Inhibitors Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Dipeptidyl Peptidase-4 Inhibitors Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Dipeptidyl Peptidase-4 Inhibitors Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Region (2019-2024) & (%)
Table 44. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Region (2025-2030) & (%)
Table 45. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Region (2019-2024) & (%)
Table 49. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Region (2025-2030) & (%)
Table 50. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Dipeptidyl Peptidase-4 Inhibitors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Dipeptidyl Peptidase-4 Inhibitors Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Dipeptidyl Peptidase-4 Inhibitors Sales Volume, (2025-2030) & (K Units)
Table 57. Merck Company Information
Table 58. Merck Introduction and Business Overview
Table 59. Merck Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Merck Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 61. Merck Recent Development
Table 62. Boehringer Ingelheim Company Information
Table 63. Boehringer Ingelheim Introduction and Business Overview
Table 64. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 66. Boehringer Ingelheim Recent Development
Table 67. AstraZeneca Company Information
Table 68. AstraZeneca Introduction and Business Overview
Table 69. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 71. AstraZeneca Recent Development
Table 72. Takeda Pharmaceutical Company Information
Table 73. Takeda Pharmaceutical Introduction and Business Overview
Table 74. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 76. Takeda Pharmaceutical Recent Development
Table 77. Novartis Company Information
Table 78. Novartis Introduction and Business Overview
Table 79. Novartis Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Novartis Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 81. Novartis Recent Development
Table 82. Jiangsu Hansoh Pharmaceutical Company Information
Table 83. Jiangsu Hansoh Pharmaceutical Introduction and Business Overview
Table 84. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 86. Jiangsu Hansoh Pharmaceutical Recent Development
Table 87. Qilu Pharmaceutical Company Information
Table 88. Qilu Pharmaceutical Introduction and Business Overview
Table 89. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 91. Qilu Pharmaceutical Recent Development
Table 92. Beijing Tide Pharmaceutical Company Information
Table 93. Beijing Tide Pharmaceutical Introduction and Business Overview
Table 94. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 96. Beijing Tide Pharmaceutical Recent Development
Table 97. CTTQ Company Information
Table 98. CTTQ Introduction and Business Overview
Table 99. CTTQ Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. CTTQ Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 101. CTTQ Recent Development
Table 102. Jiangsu Deyuan Pharmaceutical Company Information
Table 103. Jiangsu Deyuan Pharmaceutical Introduction and Business Overview
Table 104. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 106. Jiangsu Deyuan Pharmaceutical Recent Development
Table 107. Jiujiang Zhongtian Pharmaceutical Company Information
Table 108. Jiujiang Zhongtian Pharmaceutical Introduction and Business Overview
Table 109. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 111. Jiujiang Zhongtian Pharmaceutical Recent Development
Table 112. Yabao Pharmaceutical Company Information
Table 113. Yabao Pharmaceutical Introduction and Business Overview
Table 114. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Offerings
Table 116. Yabao Pharmaceutical Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Dipeptidyl Peptidase-4 Inhibitors Downstream Customers
Table 120. Dipeptidyl Peptidase-4 Inhibitors Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Dipeptidyl Peptidase-4 Inhibitors Product Picture
Figure 2. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume (2019-2030) & (K Units)
Figure 5. Global Dipeptidyl Peptidase-4 Inhibitors Sales Price (2019-2030) & (US$/Unit)
Figure 6. Dipeptidyl Peptidase-4 Inhibitors Report Years Considered
Figure 7. Global Dipeptidyl Peptidase-4 Inhibitors Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Dipeptidyl Peptidase-4 Inhibitors Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dipeptidyl Peptidase-4 Inhibitors Revenue in 2023
Figure 10. Dipeptidyl Peptidase-4 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Sitagliptin Picture
Figure 12. Saxagliptin Picture
Figure 13. Vildagliptin Picture
Figure 14. Linagliptin Picture
Figure 15. Alogliptin Picture
Figure 16. Other Picture
Figure 17. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value Market Share by Type, 2023 & 2030
Figure 19. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 20. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume Market Share by Type, 2023 & 2030
Figure 21. Global Dipeptidyl Peptidase-4 Inhibitors Price by Type (2019-2030) & (US$/Unit)
Figure 22. Product Picture of Hospital
Figure 23. Product Picture of Clinic
Figure 24. Product Picture of Other
Figure 25. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Dipeptidyl Peptidase-4 Inhibitors Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Dipeptidyl Peptidase-4 Inhibitors Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Dipeptidyl Peptidase-4 Inhibitors Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Dipeptidyl Peptidase-4 Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Dipeptidyl Peptidase-4 Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Dipeptidyl Peptidase-4 Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Dipeptidyl Peptidase-4 Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Dipeptidyl Peptidase-4 Inhibitors Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Dipeptidyl Peptidase-4 Inhibitors Sales Volume (%), (2019-2030)
Figure 42. United States Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 48. China Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 50. China Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 60. India Dipeptidyl Peptidase-4 Inhibitors Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Dipeptidyl Peptidase-4 Inhibitors Sales Value by Type (%), 2023 VS 2030
Figure 62. India Dipeptidyl Peptidase-4 Inhibitors Sales Value by Application (%), 2023 VS 2030
Figure 63. Dipeptidyl Peptidase-4 Inhibitors Industrial Chain
Figure 64. Dipeptidyl Peptidase-4 Inhibitors Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
